• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 σR/TMEM97 配体的结构-亲和力关系。

Structure-Affinity relationships of novel σR/TMEM97 ligands.

机构信息

Department of Chemistry, The University of Texas at Austin, Austin, TX 78712, United States.

Department of Chemistry, The University of Texas at Austin, Austin, TX 78712, United States.

出版信息

Bioorg Chem. 2024 Apr;145:107191. doi: 10.1016/j.bioorg.2024.107191. Epub 2024 Feb 10.

DOI:10.1016/j.bioorg.2024.107191
PMID:38432153
Abstract

The sigma 2 receptor (σR), which was recently identified as the transmembrane protein 97 (TMEM97), is increasingly attracting interest as a possible therapeutic target for indications in neuroscience. Toward identifying novel modulators of σR/TMEM97, we prepared a collection of benzoxazocine, benzomorphan, and methanobenzazepine ligands related to the known bioactive norbenzomorphans DKR-1677, FEM-1689, and EES-1686 and determined their K values for σR/TMEM97 and the sigma 1 receptor (σR). The σR/TMEM97 binding affinities and selectivities relative to σR of these new benzoxazocine, benzomorphan, and methanobenzazepine analogs are lower, often significantly lower, than their respective norbenzomorphan counterparts, suggesting the spatial orientation of pharmacophoric substituents is critical for binding to the two proteins. The benzoxazocine, benzomorphan, and methanobenzazepine congeners of DKR-1677 and FEM-1689 tend to be weakly selective for σR/TMEM97 versus σR, whereas EES-1686 derivatives exhibit the greatest selectivity, suggesting the size and/or nature of the substituent on the nitrogen atom of the scaffold may be important for selectivity. Computational docking studies were performed for the 1S,5R-and 1R,5S-enantiomers of DKR-1677, FEM-1689, and EES-1686 and their benzoxazocine, benzomorphan, and methanobenzazepine counterparts. These computations predict that the protonated amino group of each ligand forms a highly conserved salt bridge and a H-bonding interaction with Asp29 as well as a cation-π interaction with Tyr150 of σR/TMEM97. These electrostatic interactions are major driving forces for binding to σR/TMEM97 and are similar, though not identical, for each ligand. Other interactions within the well-defined binding pocket also tend to be comparable, but there are some major differences in how the hydrophobic aryl groups of various ligands interact with the protein surface external to the binding pocket. Overall, these studies show that the orientations of aryl and N-substituents on the norbenzomorphan and related scaffolds are important determinants of binding affinity of σR/TMEM97 ligands, and small changes can have significant effects upon binding profiles.

摘要

最近被鉴定为跨膜蛋白 97(TMEM97)的 sigma 2 受体(σR),作为神经科学领域各种适应症的潜在治疗靶点,正日益受到关注。为了鉴定 σR/TMEM97 的新型调节剂,我们制备了一系列与已知生物活性的 norbenzomorphans DKR-1677、FEM-1689 和 EES-1686 相关的苯并恶唑嗪、苯并吗啡烷和甲苯并氮杂䓬配体,并测定了它们对 σR/TMEM97 和 sigma 1 受体(σR)的 K 值。这些新的苯并恶唑嗪、苯并吗啡烷和甲苯并氮杂䓬类似物对 σR/TMEM97 的 σR 结合亲和力和选择性通常明显低于其相应的 norbenzomorphan 对应物,这表明药效团取代基的空间取向对于与两种蛋白的结合至关重要。DKR-1677 和 FEM-1689 的苯并恶唑嗪、苯并吗啡烷和甲苯并氮杂䓬同系物对 σR/TMEM97 相对于 σR 的选择性较弱,而 EES-1686 衍生物的选择性最大,这表明支架氮原子上取代基的大小和/或性质可能对选择性很重要。对 DKR-1677、FEM-1689 和 EES-1686 的 1S,5R-和 1R,5S-对映异构体及其苯并恶唑嗪、苯并吗啡烷和甲苯并氮杂䓬类似物进行了计算对接研究。这些计算预测,每个配体的质子化氨基形成高度保守的盐桥和与 Asp29 的氢键相互作用以及与 σR/TMEM97 的 Tyr150 的阳离子-π 相互作用。这些静电相互作用是与 σR/TMEM97 结合的主要驱动力,对于每种配体都是相似的,尽管不完全相同。在定义明确的结合口袋内的其他相互作用也往往是可比的,但各种配体的疏水性芳基与结合口袋外部的蛋白质表面的相互作用有一些重大差异。总体而言,这些研究表明,norbenzomorphan 及其相关支架上的芳基和 N-取代基的取向是 σR/TMEM97 配体结合亲和力的重要决定因素,微小的变化会对结合谱产生重大影响。

相似文献

1
Structure-Affinity relationships of novel σR/TMEM97 ligands.新型 σR/TMEM97 配体的结构-亲和力关系。
Bioorg Chem. 2024 Apr;145:107191. doi: 10.1016/j.bioorg.2024.107191. Epub 2024 Feb 10.
2
Structure-affinity relationships of stereoisomers of norbenzomorphan-derived σR/TMEM97 modulators.苯并吗啡烷衍生的 σR/TMEM97 调节剂立体异构体的结构-亲和力关系。
Eur J Med Chem. 2023 Sep 5;257:115488. doi: 10.1016/j.ejmech.2023.115488. Epub 2023 May 23.
3
Preparation of novel analogs of 2-arylpiperidines and evaluation of their sigma receptor binding affinities.新型 2-芳基哌啶类似物的制备及其 sigma 受体结合亲和力评估。
Eur J Med Chem. 2022 May 5;235:114310. doi: 10.1016/j.ejmech.2022.114310. Epub 2022 Mar 23.
4
Targeting σR/TMEM97 with novel aminotetralins.靶向 σR/TMEM97 的新型氨基四氢萘。
Eur J Med Chem. 2022 Dec 5;243:114696. doi: 10.1016/j.ejmech.2022.114696. Epub 2022 Aug 28.
5
Characterization of Sigma-2 Receptor-Specific Binding Sites Using [H]DTG and [I]RHM-4.使用[H]DTG和[I]RHM-4对西格玛-2受体特异性结合位点进行表征。
Pharmaceuticals (Basel). 2022 Dec 15;15(12):1564. doi: 10.3390/ph15121564.
6
Synthesis, binding, and functional properties of tetrahydroisoquinolino-2-alkyl phenones as selective σR/TMEM97 ligands.四氢异喹啉-2-烷基苯酮作为选择性 σR/TMEM97 配体的合成、结合和功能性质。
Eur J Med Chem. 2021 Jan 1;209:112906. doi: 10.1016/j.ejmech.2020.112906. Epub 2020 Oct 7.
7
Investigating isoindoline, tetrahydroisoquinoline, and tetrahydrobenzazepine scaffolds for their sigma receptor binding properties.研究异吲哚、四氢异喹啉和四氢苯并氮杂䓬骨架的 sigma 受体结合特性。
Eur J Med Chem. 2018 May 10;151:557-567. doi: 10.1016/j.ejmech.2018.02.024. Epub 2018 Mar 29.
8
Neuroprotective Effects of σR/TMEM97 Receptor Modulators in the Neuronal Model of Huntington's Disease.σR/TMEM97 受体调节剂在亨廷顿病神经元模型中的神经保护作用。
ACS Chem Neurosci. 2022 Oct 5;13(19):2852-2862. doi: 10.1021/acschemneuro.2c00274. Epub 2022 Sep 15.
9
Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice.Sigma 2 受体/Tmem97 激动剂在小鼠中产生持久的抗神经病理性疼痛作用。
ACS Chem Neurosci. 2017 Aug 16;8(8):1801-1811. doi: 10.1021/acschemneuro.7b00200. Epub 2017 Jul 13.
10
Bridging Known and Unknown Unknowns: From Natural Products and Their Mimics to Unmet Needs in Neuroscience.连接已知与未知的未知:从天然产物及其模拟物到神经科学中未满足的需求
Acc Chem Res. 2022 Sep 6;55(17):2397-2408. doi: 10.1021/acs.accounts.1c00773. Epub 2022 Aug 12.

引用本文的文献

1
Discovery of Iboga-Derived Ligands for the Sigma‑2 Receptor.伊博格碱衍生的西格玛-2受体配体的发现。
ACS Bio Med Chem Au. 2025 May 12;5(3):379-386. doi: 10.1021/acsbiomedchemau.5c00011. eCollection 2025 Jun 18.
2
Recent Advances in the Development of Sigma Receptor (Radio)Ligands and Their Application in Tumors.σ受体(放射性)配体的开发进展及其在肿瘤中的应用
ACS Pharmacol Transl Sci. 2025 Mar 7;8(4):951-977. doi: 10.1021/acsptsci.4c00711. eCollection 2025 Apr 11.
3
Recent Developments in Sigma-2 Receptor Compounds for Pain.
用于疼痛治疗的西格玛-2受体化合物的最新进展
Cureus. 2024 May 8;16(5):e59882. doi: 10.7759/cureus.59882. eCollection 2024 May.